Clinical Trial Update: CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for CORETOX® in post-stroke upper limb spasticity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasticity
• Post-stroke Spasticity
• Upper Limb Spasticity

Drugs mentioned

• CORETOX

Snippet

Sponsor: Medy-Tox | Conditions: Muscle Spasticity | Phase 3 | Status: COMPLETED